GaryCraigReidMD

Obstetrics & Gynecology • Columbus, OH

Gynecologic Oncology

Obstetrician-gynecologist in Columbus, Ohio and is affiliated with OhioHealth Riverside Methodist Hospital

Join to view full profile

Dr. Reid is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Reid's full profile

Already have an account?

Office
3535 Olentangy River Rd
Columbus, OH 43214
Phone+1 614-538-0440

Fax+1 614-566-6906
Is this information wrong?

Education & Training

University of Michigan Health SystemFellowship, Gynecologic Oncology, 1986 - 1988
University of Michigan Health SystemResidency, Obstetrics and Gynecology, 1977 - 1981
Northwestern University The Feinberg School of MedicineClass of 1977

Certifications & Licensure

OH State Medical License 1988 - 2026
MI State Medical License 1979 - 1990
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

3 citations
Cervical cancer radiation therapy compliance rates based on location of radiation therapy.
Corinne A. Calo, John O. Elliott, Aine Clements, Gary C. Reid, Kellie S. Rath> ;Gynecologic Oncology. 2019 Mar 1
13 citations
A persistent mass: A case of aggressive Angiomyxoma of the vulva.
B.N. Brzezinska, Aine Clements, Kellie S. Rath, Gary C. Reid> ;Gynecologic Oncology Reports. 2018 May 1
11 citations
Outcomes of patients with low-risk endometrial cancer surgically staged without lymphadenectomy based on intra-operative evaluation.
Jeffrey G. Bell, Diana M. Patterson, Jennifer Klima, Michelle Harvison, Kellie S. Rath, Gary C. Reid> ;Gynecologic Oncology. 2014 Sep 1
The prognostic role of calretinin expression and neutrophil-to-lymphocyte ratio (NLR) in patients with malignant pleural mesothelioma (MPM) undergoing extrapleural pne...
Kao SC, Klebe S, Henderson D, Reid G, Chatfield MD, Armstrong N, Yan T, Vardy JL, Clarke SJ, Van Zandwijk N, McCaughan B> ;J. Clin. Oncol.. 2011-05-20
Malignant mesothelioma.
Kao SC, Reid G, Lee K, Vardy J, Clarke S, van Zandwijk N> ;Intern Med J. 2010-11-01
45 citations
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
Carol Aghajanian, John A. Blessing, Kathleen M. Darcy, Gary C. Reid, Koen DeGeest, Stephen C. Rubin, Robert S. Mannel, Jacob Rotmensch, Russell J. Schilder, William Ri...> ;Gynecologic Oncology. 2009 Nov 1
12 citations
Are prediction models for Lynch syndrome valid for probands with endometrial cancer
Floor J. Backes, Heather Hampel, Katherine A. Backes, Luis Vaccarello, George S. Lewandowski, Jeffrey A. Bell, Gary C. Reid, Larry J. Copeland, Jeffrey M. Fowler, Davi...> ;Familial Cancer. 2009 Jul 30
Phase I study of daily administration of MGCD265 to patients with advanced malignancies (Study 265-101).
Kollmannsberger CK, Hurwitz H, Vlahovic G, Maroun C, Dumouchel J, Reid G, Martell R, Shapiro G> ;J. Clin. Oncol.. 2009-05-20
Clinical activity and safety of the histone deacetylase inhibitor MGCD0103: Results of a phase I study in patients with leukemia or myelodysplastic syndromes (MDS).
Garcia-Manero G, Minden M, Estrov Z, Verstovsek S, Newsome WM, Reid G, Besterman J, Li Z, Pearce L, Martell R> ;J. Clin. Oncol.. 2006-06-20
28 citations
Phase II trial of liposomal doxorubicin at 40 mg/m2 every 4 weeks in endometrial carcinoma: A Gynecologic Oncology Group Study
Howard D. Homesley, John A. Blessing, Joel I. Sorosky, Gary Reid, Katherine Y. Look> ;Gynecologic Oncology. 2005 Aug 1
Phase II trial of liposomal doxorubicinin disseminated endometrial carcinoma: A Gynecologic Oncology Group study.
Homesley HD, Blessing JA, Sorosky JI, Reid GC, Look KY> ;J. Clin. Oncol.. 2005-06-01
47 citations
Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature.
Ronald D. Hardy, Jeffrey G. Bell, Charles J. Nicely, Gary C. Reid> ;Gynecologic Oncology. 2005 Mar 1
Identification of immune evasion strategies of pediatric pre-B acute lymphoblastic leukemia after bone marrow transplantation.
Barbaric D, Schultz K, Reid G> ;J. Clin. Oncol.. 2004-07-15
379 citations
Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study
Gini F. Fleming, Virginia L. Brunetto, David Cella, Katherine Y. Look, Gary C. Reid, Adnan R. Munkarah, Richard Kline, Robert A. Burger, Annekathryn Goodman, R. Tucker...> ;Journal of Clinical Oncology. 2004 Jun 1
79 citations
Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial ...
Holly H. Gallion, Virginia L. Brunetto, Michael L. Cibull, Samuel S. Lentz, Gary Reid, John T. Soper, Robert A. Burger, Willie A. Andersen> ;Journal of Clinical Oncology. 2003 Oct 15
45 citations
Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Robert F. Asbury, Virginia L. Brunetto, Roger B. Lee, Gary C. Reid, Thomas F. Rocereto> ;American Journal of Clinical Oncology. 2002 Dec 1
131 citations
Phase II Trial of the Pegylated Liposomal Doxorubicin in Previously Treated Metastatic Endometrial Cancer: A Gynecologic Oncology Group Study
Franco M. Muggia, John A. Blessing, Joel I. Sorosky, Gary C. Reid> ;Journal of Clinical Oncology. 2002 May 1
50 citations
Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma.
Jeffrey G. Bell, Jayanthi S. Lea, Gary C. Reid> ;Gynecologic Oncology. 2000 May 1
25 citations
Dactinomycin in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group
David H. Moore, John A. Blessing, Charles J. Dunton, Richard E. Buller, Gary C. Reid> ;Gynecologic Oncology. 1999 Dec 1
16 citations
A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
Katherine Y. Look, John A. Blessing, Beth E. Nelson, G. A. Johnson, Wesley C. Fowler, Gary C. Reid> ;American Journal of Clinical Oncology. 1998 Dec 1
2 citations
A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group Study.
Robert F. Asbury, John A. Blessing, Gary C. Reid, William McGuire> ;American Journal of Clinical Oncology. 1998 Aug 1
21 citations
Relationship of Nonstaging Pathological Risk Factors to Lymph Node Metastasis and Recurrence in Clinical Stage I Endometrial Carcinoma
Jeffrey G. Bell, Angela Minnick, Gary C. Reid, Jeffrey Judis, Mark Brownell> ;Gynecologic Oncology. 1997 Sep 1
High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Lentz SS, Brady MF, Major FJ, Reid GC, Soper JT> ;J. Clin. Oncol.. 1996-02-01
41 citations
Radical vulvectomy : the decision for the incision
Michael P. Hopkins, Gary C. Reid, George W. Morley> ;Cancer. 1993 Aug 1
1 citations
Primary Treatment of Stage III Ovarian Carcinoma with Sequential Chemotherapy and Whole Abdominal Radiation Therapy
Gary C. Reid, James A. Roberts, Michael P. Hopkins, Sonja L. Schoeppel, Claudia Perez-Tamayo, Charles W. Drescher, Donald H. Chamberlain, George W. Morley> ;Gynecologic Oncology. 1993 Jun 1
Join now to see all

Press Mentions

Dual Chemotherapy Boosts Survival Rates for Ovarian Cancer PatientsAugust 3rd, 2015

Professional Memberships

American College of Surgeons - ACS
Member

Hospital Affiliations

OhioHealth Riverside Methodist HospitalColumbus, Ohio